Literature DB >> 7666532

Retroviral retargeting by envelopes expressing an N-terminal binding domain.

F L Cosset1, F J Morling, Y Takeuchi, R A Weiss, M K Collins, S J Russell.   

Abstract

We have engineered ecotropic Moloney murine leukemia virus-derived envelopes targeted to cell surface molecules expressed on human cells by the N-terminal insertion of polypeptides able to bind either Ram-1 phosphate transporter (the first 208 amino acids of amphotropic murine leukemia virus surface protein) or epidermal growth factor receptor (EGFR) (the 53 amino acids of EGF). Both envelopes were correctly processed and incorporated into viral particles. Virions carrying these envelopes could specifically bind the new cell surface receptors. Virions targeted to Ram-1 could infect human cells, although the efficiency was reduced compared with that of virions carrying wild-type amphotropic murine leukemia virus envelopes. The infectivity of virions targeted to EGFR was blocked at a postbinding step, and our results suggest that EGFR-bound virions were rapidly trafficked to lysosomes. These data suggest that retroviruses require specific properties of cell surface molecules to allow the release of viral cores into the correct cell compartment.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7666532      PMCID: PMC189530     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  Receptor choice determinants in the envelope glycoproteins of amphotropic, xenotropic, and polytropic murine leukemia viruses.

Authors:  J L Battini; J M Heard; O Danos
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

2.  Characterization of a human gene conferring sensitivity to infection by gibbon ape leukemia virus.

Authors:  B O'Hara; S V Johann; H P Klinger; D G Blair; H Rubinson; K J Dunn; P Sass; S M Vitek; T Robins
Journal:  Cell Growth Differ       Date:  1990-03

3.  Cell-surface receptor for ecotropic murine retroviruses is a basic amino-acid transporter.

Authors:  H Wang; M P Kavanaugh; R A North; D Kabat
Journal:  Nature       Date:  1991-08-22       Impact factor: 49.962

Review 4.  Epidermal growth factor.

Authors:  G Carpenter; S Cohen
Journal:  J Biol Chem       Date:  1990-05-15       Impact factor: 5.157

5.  The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites: a possible function in viral fusion?

Authors:  G J Clements; M J Price-Jones; P E Stephens; C Sutton; T F Schulz; P R Clapham; J A McKeating; M O McClure; S Thomson; M Marsh
Journal:  AIDS Res Hum Retroviruses       Date:  1991-01       Impact factor: 2.205

6.  Basis for receptor specificity of nonecotropic murine leukemia virus surface glycoprotein gp70SU.

Authors:  D Ott; A Rein
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

7.  Feline leukemia virus subgroup B uses the same cell surface receptor as gibbon ape leukemia virus.

Authors:  Y Takeuchi; R G Vile; G Simpson; B O'Hara; M K Collins; R A Weiss
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

8.  Cell targeting with retroviral vector particles containing antibody-envelope fusion proteins.

Authors:  T H Chu; I Martinez; W C Sheay; R Dornburg
Journal:  Gene Ther       Date:  1994-09       Impact factor: 5.250

9.  Disulfide bonding controls the processing of retroviral envelope glycoproteins.

Authors:  B C Gliniak; S L Kozak; R T Jones; D Kabat
Journal:  J Biol Chem       Date:  1991-12-05       Impact factor: 5.157

10.  Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding.

Authors:  Q J Sattentau; J P Moore
Journal:  J Exp Med       Date:  1991-08-01       Impact factor: 14.307

View more
  71 in total

1.  Retroviral vectors preloaded with a viral receptor-ligand bridge protein are targeted to specific cell types.

Authors:  A L Boerger; S Snitkovsky; J A Young
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

2.  Identification of the block in targeted retroviral-mediated gene transfer.

Authors:  Y Zhao; L Zhu; S Lee; L Li; E Chang; N W Soong; D Douer; W F Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

3.  Two point mutations produce infectious retrovirus bearing a green fluorescent protein-SU fusion protein.

Authors:  K Kizhatil; A Gromley; L M Albritton
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

4.  Role of chimeric murine leukemia virus env beta-turn polyproline spacers in receptor cooperation.

Authors:  S Valsesia-Wittmann
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

5.  Redirecting retroviral tropism by insertion of short, nondisruptive peptide ligands into envelope.

Authors:  Timothy J Gollan; Michael R Green
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

6.  Selective targeting and inducible destruction of human cancer cells by retroviruses with envelope proteins bearing short peptide ligands.

Authors:  Timothy J Gollan; Michael R Green
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

7.  A TVA-single-chain antibody fusion protein mediates specific targeting of a subgroup A avian leukosis virus vector to cells expressing a tumor-specific form of epidermal growth factor receptor.

Authors:  S Snitkovsky; T M Niederman; B S Carter; R C Mulligan; J A Young
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

8.  Sensitization of rhabdo-, lenti-, and spumaviruses to human serum by galactosyl(alpha1-3)galactosylation.

Authors:  Y Takeuchi; S H Liong; P D Bieniasz; U Jäger; C D Porter; T Friedman; M O McClure; R A Weiss
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

9.  Receptor co-operation in retrovirus entry: recruitment of an auxiliary entry mechanism after retargeted binding.

Authors:  S Valsesia-Wittmann; F J Morling; T Hatziioannou; S J Russell; F L Cosset
Journal:  EMBO J       Date:  1997-03-17       Impact factor: 11.598

10.  Comparison of the convergent receptor utilization of a retargeted feline leukemia virus envelope with a naturally-occurring porcine endogenous retrovirus A.

Authors:  Peter M Mazari; Takele Argaw; Leonardo Valdivieso; Xia Zhang; Katherine T Marcucci; Daniel R Salomon; Carolyn A Wilson; Monica J Roth
Journal:  Virology       Date:  2012-03-08       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.